Herbalife earnings date
Herbalife (HOO) Q3 2026 Earnings Report
DE:HOO Q3 2026 EPS Results
- Actual EPS
- EUR 0.57
- Consensus EPS
- EUR 0.55
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- EUR 0.44
DE:HOO Q3 2026 Revenue Results
- Actual Revenue
- EUR 1.20B
- Expected Revenue
- EUR 1.16B
- Beat/Miss
- Beat by +EUR 38.37M
- YoY Revenue Growth
- +6.01%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/02/2026
- Time
- After Close
- Conference Call
- Monday, November 2, 2026
Herbalife's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was predominantly positive, supported by a fifth consecutive quarter of net sales and volume growth, results above quarterly guidance, improved adjusted EBITDA margin, strong cash generation, reduced leverage, raised full-year net sales and constant currency EBITDA guidance, and multiple growth initiatives. The company also disclosed challenges including FX headwinds, lower gross profit margin, unfavorable mix and input costs, weaker contributions from EMEA and China, lower fourth-quarter margin guidance, and early-stage adoption of Bioniq and Pro2col.
For the fourth quarter, Herbalife expects reported net sales to increase 0.5% to 4.5% year-over-year, including a 200 basis point currency headwind, and constant currency net sales to increase 2.5% to 6.5% year-over-year; adjusted EBITDA is expected to be in the range of $145 million to $165 million on a reported basis and in the range of $155 million to $175 million on a constant currency basis, with capital expenditures in the range of $13 million to $23 million. For the full year, reported net sales are expected to increase 4.9% to 5.9% year-over-year and constant currency net sales to increase 5.3% to 6.3%; reported adjusted EBITDA is maintained at $670 million to $690 million and constant currency adjusted EBITDA is raised to $700 million to $720 million; 2026 capital expenditures are expected to be $55 million to $65 million, narrowed from previous guidance, and capitalized and prepaid SaaS implementation costs of $35 million to $45 million, also narrowed, are incremental to CapEx, while the company continues to expect approximately 35% for the full year for its adjusted effective tax rate. The company is targeting the first quarter of 2027 to begin introducing new technology capabilities, and its goal is to capture at least 50% of its distributors' global consumer transactions within its technology ecosystem over the next three years.
- Net Sales Exceeded Guidance and Grew for Fifth Consecutive QuarterThird-quarter net sales were $1.4 billion, increasing 6% year-over-year on a reported basis and 7.6% on a constant currency basis. Results exceeded the guidance range of up 0.5% to 4.5% on a reported basis and up 1.5% to 5.5% on a constant currency basis. This was the fifth consecutive quarter of year-over-year net sales growth on both reported and constant currency bases.
- Adjusted EBITDA and Margin ImprovedAdjusted EBITDA was $182 million, exceeding the guidance range of $160 million to $180 million. Adjusted EBITDA margin improved 70 basis points year-over-year to 13.5%.
- Net Income and Adjusted EPS IncreasedThird-quarter net income attributable to Herbalife was $59 million, up 36% year-over-year. Adjusted net income was approximately $69 million. Diluted EPS was $0.55, up $0.13 year-over-year, while adjusted diluted EPS was $0.64, up $0.14, including a $0.06 FX headwind versus the third quarter of 2025.
- Strong Global Volume GrowthWorldwide volume increased 8.6%, marking the fifth consecutive quarter of year-over-year volume growth. Pricing provided an approximately $36 million benefit in the quarter.
- Asia Pacific and India Led Regional GrowthAsia Pacific constant currency net sales increased 26%, with India the primary driver. India's net sales increased $87 million year-over-year, or 39% and 52% in local currency, on nearly 50% volume growth. The company said the GST change in the third quarter of 2025 added momentum to an Indian business that was already growing.
- Growth in Latin America and North AmericaLatin America grew 5.1% in constant currency and 9% on a reported basis. North America net sales increased 1.7%, marking its second consecutive quarter of year-over-year growth. The company said a revenue-recognition timing shift from the first quarter to the third quarter contributed to North America's growth versus last year.
- Operating Cash Flow and Liquidity StrengthenedYear-to-date operating cash flow was $298 million, up $63 million, or approximately 27%, versus the first nine months of 2025. The company generated more than $151 million of operating cash flow during the quarter and finished the period with $409 million of cash.
- Leverage Improved and Debt Was ReducedNet leverage was 2.0x at quarter-end, down from 2.2x at the end of the second quarter and at the company's target of at or below 2x. The company paid down $88 million of debt and had only $50 million outstanding under its revolving credit facility.
- Refinancing Reduced Interest Expense and Extended MaturitiesThe April refinancing, combined with continued debt paydown, reduced net interest expense by $19 million year-over-year in the quarter. The refinancing extended the maturity profile, with no significant maturity until the 2028 convertible notes.
- Share Repurchase Program AuthorizedHerbalife authorized a $250 million share repurchase program and plans to begin repurchasing shares in the fourth quarter, executing the program systematically and opportunistically over time.
- Full-Year Net Sales Guidance RaisedFull-year reported net sales guidance was raised to growth of 4.9% to 5.9% year-over-year, while constant currency net sales guidance was raised to growth of 5.3% to 6.3%.
- Full-Year Constant Currency EBITDA Guidance RaisedFull-year reported adjusted EBITDA guidance was maintained at $670 million to $690 million, while constant currency adjusted EBITDA guidance was raised to $700 million to $720 million.
- Nutrition Club Scale and Productivity IncreasedHerbalife has more than 64,000 Nutrition Clubs globally, including almost 9,000 in the U.S. U.S. Nutrition Clubs accounted for 42% of U.S. volume in the third quarter, and club productivity increased over 10% year-over-year in each quarter of 2026. Customers coming through the door increased more than 7% this quarter, along with increased visit frequency.
- Dedicated Nutrition Club Organization PlannedThe company plans to establish an internal Nutrition Club organization focused on helping distributors grow their club businesses through better tools, Nutrition Club-specific products, tailored programs and training, and more coordinated support while preserving regional and distributor flexibility.
- Customer Engagement Technology Platform in DevelopmentHerbalife is building a common modular technology foundation that will support different distributor business models and combine capabilities currently spread across separate tools, outside apps and manual processes. The company is targeting the first quarter of 2027 to begin introducing new capabilities, starting with the 24 games and followed by additional programs.
- Technology Ecosystem Transaction Capture TargetThe company aims to capture at least 50% of distributors' global consumer transactions within its technology ecosystem over the next three years. The platform is intended to provide consumer engagement, retention and growth insights and help the company understand consumer needs and develop products and services.
- Bioniq Expansion PlannedHerbalife is expanding Bioniq from primarily a personalized nutrition business into a premium health and wellness brand spanning personalized nutrition, sports performance and healthy lifespan. Throughout 2027, the company plans to offer more convenient formats and premium offerings, including additional personalized nutrition SKUs.
- Bioniq to Include Life I/O and Sports OfferingsManagement plans to roll Life I/O into Bioniq, launch sports within the Bioniq brand and create a business opportunity within the Bioniq brand that remains part of Herbalife. Management said Bioniq could reach consumers in certain markets and demographics that the Herbalife brand may not reach.
- GLP-1 Program Using Current ProductsHerbalife is developing a program for its current products to be used by consumers taking GLP-1 medication. Management said the strategy is focused on positioning current products for use alongside GLP-1 rather than developing new products.
- Broader Growth Initiatives and Community-Based EngagementThe company is expanding support for other distributor business models, broadening the global reach of its skin care offerings, and developing nutritional products and programs for evolving consumer needs, including people using GLP-1 medications. Herbalife also held its first U.S. 24 games event in Miami, bringing together more than 350 attendees.
- Capital Allocation Continues to Prioritize Business InvestmentHerbalife said it will continue investing in the business, prioritizing opportunities across its distributor network, product portfolio and digital capabilities to support sustainable long-term growth.
DE:HOO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | 0.50- | 0.4 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 0.550.57 | 0.44 | 28.00% (+0.12) | |
| Aug 05, 2026 | 2026 (Q2) | 0.480.45 | 0.52 | -13.56% (-0.07) | |
| May 06, 2026 | 2026 (Q1) | 0.540.57 | 0.52 | 8.47% (+0.04) | |
| Feb 18, 2026 | 2025 (Q4) | 0.420.40 | 0.32 | 25.00% (+0.08) | |
| Nov 05, 2025 | 2025 (Q3) | 0.410.44 | 0.51 | -12.28% (-0.06) | |
| Aug 06, 2025 | 2025 (Q2) | 0.440.52 | 0.48 | 9.26% (+0.04) | |
| Apr 30, 2025 | 2025 (Q1) | 0.360.52 | 0.44 | 20.41% (+0.09) | |
| Feb 19, 2025 | 2024 (Q4) | 0.170.32 | 0.25 | 28.57% (+0.07) | |
| Oct 30, 2024 | 2024 (Q3) | 0.280.51 | 0.58 | -12.31% (-0.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


